The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Discover effective ways to earn money fast from home. Explore work-from-home opportunities that can help boost your income.
15,876 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
As 2026 approaches, a clash between Uber and DoorDash for the title of the better growth stock 2026 unfolds. This art...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Meta Platforms has shown strong top-line momentum, but rising AI-related costs and shifting margins could pressure ea...
Are you leaning toward megacap growth or small-cap opportunities? This guide breaks down MGK vs IWM, reveals how to b...
Oil markets jump as Iran keeps Strait Hormuz under pressure, signaling potential disruption to energy flows. Investor...
Meta Platforms unveils a multi-year AI infrastructure push totaling up to $145 billion, reshaping supplier valuations...
As the 10-year Treasury crosses 4.6%, ETF dynamics for VOO and IVV face renewed scrutiny. Markets weigh rate paths, i...
Rivian stock may get a lift not just from its R2 ramp but from a larger tech ecosystem catalyst: the potential SpaceX...
A high-stakes reminder that transportation investments hinge on cash flow, leverage, and portfolio balance. This piec...
Morgan Stanley’s MSBT ends its debut month with zero net outflows and a six-week inflow streak, underscoring growing ...